Biopsy, Slide(s) & Block(s) for review (Return to Patient) at Chughtai Lab

Biopsy, Slide(s) & Block(s) for review (Return to Patient) at Chughtai Lab

The diagnostic journey for complex medical conditions, particularly oncological, inflammatory, and autoimmune disorders, relies heavily on the accuracy of histopathological evaluation. A biopsy involves the surgical removal of a small tissue specimen from the body to examine it for signs of disease. Once this tissue is processed in a laboratory, it is embedded in paraffin wax to create tissue blocks, and thin sections are cut and mounted onto glass slides for microscopic examination. The service of Biopsy, Slide(s) & Block(s) for review (Return to Patient) at Chughtai Lab provides patients and referring physicians with an expert, independent second opinion on these prepared tissue specimens. This diagnostic review is critical to confirming initial diagnoses, refining tumor classifications, and ensuring that the subsequent treatment plan is based on highly accurate pathological findings.

Histopathology is a highly specialized field of medicine where pathologists interpret cellular patterns, tissue architecture, and nuclear features to differentiate between benign and malignant conditions. Because treatment protocols, surgical margins, and systemic therapies depend entirely on these microscopic details, a secondary review of existing slides and blocks is widely considered a best practice in modern oncology. Chughtai Lab utilizes advanced light microscopy, digital pathology systems, and a comprehensive menu of immunohistochemical (IHC) stains to perform these reviews. The primary advantage of this service is that it does not require the patient to undergo a repeat invasive biopsy procedure. Instead, the existing diagnostic materials are re-evaluated by senior consultant pathologists who specialize in specific organ systems, ensuring the highest level of diagnostic precision.

The designation “Return to Patient” is a crucial aspect of this service. It guarantees that after the expert pathologists at Chughtai Lab have completed their comprehensive evaluation, the physical glass slides and paraffin blocks are safely returned to the patient. This ensures that the patient maintains possession of their primary diagnostic tissue, which may be required for future consultations, molecular testing, clinical trials, or further treatment planning at other national or international healthcare institutions. By preserving and returning these valuable medical assets, Chughtai Lab supports continuity of care and empowers patients to take full control of their medical records.

Clinical Procedure: What to Expect

Patient Preparation

Because the Biopsy, Slide(s) & Block(s) for review (Return to Patient) at Chughtai Lab is performed on pre-existing tissue samples, there is no direct physical preparation required from the patient. However, to ensure a seamless and highly accurate diagnostic review, patients must follow these essential administrative and preparatory guidelines:

• Gather Original Documentation: Patients must provide the original pathology report associated with the slides and blocks. This report contains critical information, including the specimen source, the initial pathologist’s findings, and the unique laboratory accession number.
• Provide Clinical History: Submit a brief clinical summary, including the patient’s age, gender, primary symptoms, imaging findings (such as CT, MRI, or ultrasound reports), and any previous treatments or surgeries. This clinical context is invaluable to the reviewing pathologist.
• Verify Specimen Labeling: Ensure that all glass slides and paraffin blocks are clearly labeled with the patient’s name, unique identification number, and the corresponding pathology case number that matches the original report.
• Ensure Safe Transport: Place the glass slides in a rigid, protective slide mailer or box to prevent breakage during transit. Paraffin blocks should be kept at room temperature and protected from extreme heat, as temperatures above 50 degrees Celsius can melt the wax and damage the tissue.
• Submit All Materials: It is highly recommended to submit all available slides and blocks from the procedure, rather than a selected few, to allow the pathologist to perform a comprehensive evaluation of the entire sampled area.

During the Procedure

The process of submitting and reviewing biopsy slides and blocks at Chughtai Lab is highly structured to maintain specimen integrity and diagnostic accuracy:

• Submission and Accessioning: The patient or their representative delivers the slides, blocks, and clinical documents to a Chughtai Lab collection center. The laboratory staff carefully inventories the submitted materials, verifies the labeling against the paperwork, and assigns a unique tracking number to the case.
• Pathology Assignment: The case is routed to the histopathology department, where it is assigned to a consultant pathologist with specialized expertise in the relevant organ system (e.g., dermatopathology, gastrointestinal pathology, gynecopathology, or hematopathology).
• Microscopic Evaluation: The pathologist examines the submitted glass slides under a high-resolution light microscope, evaluating cellular morphology, architectural patterns, inflammatory infiltrates, and nuclear atypia.
• Additional Processing (If Required): If the original slides are faded, damaged, or insufficient for a definitive diagnosis, the pathologist may request new sections to be cut from the submitted paraffin blocks. Special histochemical stains or immunohistochemistry (IHC) panels may be performed on these new sections to identify specific cellular markers.
• Report Generation and Return: Once the pathologist reaches a diagnostic conclusion, a comprehensive review report is generated. The original glass slides and paraffin blocks are then carefully repackaged and returned to the patient along with the final written report.

When is a Biopsy, Slide(s) & Block(s) for review (Return to Patient) Performed?

Confirming a Suspected Cancer Diagnosis

A second opinion on a biopsy is most frequently requested when an initial diagnosis of malignancy has been made. Because cancer treatments often involve highly invasive procedures, such as radical surgery, chemotherapy, or radiation therapy, clinicians and patients seek absolute certainty before initiating therapy. Reviewing the slides and blocks at an advanced reference laboratory like Chughtai Lab helps confirm the presence of cancer, rules out benign mimics, and ensures that the diagnosis is indisputable before treatment begins.

Subtyping Complex Tumors and Lymphomas

Many malignancies, particularly lymphomas, soft tissue sarcomas, and brain tumors, are highly complex and exhibit significant histological diversity. Accurately subtyping these tumors is essential because different subtypes respond to entirely different therapeutic regimens. A specialized review of the tissue blocks allows pathologists to perform advanced immunohistochemical staining and molecular profiling, which are necessary to pinpoint the exact subtype of the tumor and guide targeted oncological therapies.

Resolving Discrepant or Inconclusive Initial Reports

In some clinical scenarios, the initial pathology report may be inconclusive, or the findings may not align with the patient’s clinical presentation and radiological imaging. For example, if a CT scan strongly suggests a malignant tumor but the initial biopsy report indicates benign tissue, a review of the slides and blocks is warranted. The expert pathologists at Chughtai Lab can re-evaluate the tissue to determine if malignant areas were missed, if the sample was insufficient, or if a subtle pathological process was overlooked.

Facilitating Specialized Immunohistochemistry (IHC)

Many smaller laboratories lack the resources, automated equipment, and antibody libraries required to perform specialized immunohistochemical staining. When a primary pathologist suspects a condition that requires IHC for confirmation (such as determining hormone receptor status in breast cancer or identifying specific cell lineages in leukemia), the tissue blocks are sent to Chughtai Lab. The advanced pathology department can cut new sections from the blocks and run the necessary IHC panels to provide a definitive diagnosis.

Pre-Surgical Evaluation and Treatment Planning

Surgeons often require a verified pathology report from a trusted, accredited laboratory before performing major, life-altering surgeries. If a patient was diagnosed at a different facility, the surgical team may request a slide and block review at Chughtai Lab to independently verify the diagnosis, assess the tumor grade, and evaluate features such as vascular or perineural invasion. This detailed information allows the surgical team to plan the optimal surgical approach and determine the necessity of pre-operative neoadjuvant therapy.

What Does a Biopsy, Slide(s) & Block(s) for review (Return to Patient) Detect?

The comprehensive review of biopsy slides and blocks can detect, confirm, or refine a wide range of pathological conditions across various organ systems. These findings include, but are not limited to:

• Infiltrating Ductal Carcinoma: Confirming the most common form of breast cancer and evaluating histological grade.
• Adenocarcinoma of the Colon: Identifying malignant epithelial tumors of the gastrointestinal tract and assessing differentiation.
• Squamous Cell Carcinoma: Detecting malignant epithelial lesions of the skin, lungs, cervix, or oral cavity.
• Hodgkin and Non-Hodgkin Lymphoma: Classifying specific subtypes of lymphatic malignancies using morphology and IHC markers.
• Benign Epithelial Hyperplasia: Differentiating non-cancerous cellular proliferation from pre-malignant or malignant lesions.
• Chronic Inflammatory Bowel Disease: Distinguishing between Crohn’s disease and ulcerative colitis based on mucosal architectural changes.
• Granulomatous Inflammation: Detecting patterns suggestive of tuberculosis, sarcoidosis, or deep fungal infections.
• High-Grade Dysplasia: Identifying pre-cancerous cellular changes in mucosal linings, such as the cervix or esophagus.
• Malignant Melanoma: Confirming melanocytic malignancies and measuring Breslow thickness and Clark level.
• Gastrointestinal Stromal Tumors (GIST): Confirming mesenchymal tumors of the GI tract and evaluating mitotic activity.
• Soft Tissue Sarcomas: Classifying rare malignancies of connective tissues, including liposarcomas and leiomyosarcomas.
• Neuroendocrine Tumors (NETs): Grading neuroendocrine neoplasms based on mitotic count and Ki-67 proliferation index.
• Fibroadenoma: Confirming benign breast lesions and ruling out phyllodes tumors or malignancies.
• Glomerulonephritis Patterns: Evaluating renal biopsy slides to classify specific autoimmune or inflammatory kidney diseases.
• Hepatic Cirrhosis and Fibrosis: Grading and staging liver tissue to assess the extent of chronic liver damage.
• Helicobacter pylori Gastritis: Detecting spiral-shaped bacteria in gastric mucosal biopsies using special stains.
• Celiac Disease: Grading duodenal mucosal atrophy and intraepithelial lymphocytosis using the Marsh classification.
• Endometrial Hyperplasia: Differentiating between typical and atypical hyperplasia to assess uterine cancer risk.
• Deep Fungal Infections: Visualizing fungal hyphae or yeast forms in tissue sections using GMS or PAS stains.
• Tumor Margin Status: Evaluating whether the surgical margins of a resected specimen are free of tumor cells.
• Lymphovascular Invasion (LVI): Detecting the presence of tumor cells within lymphatic or blood vessels, indicating metastatic potential.
• Perineural Invasion (PNI): Identifying tumor cells tracking along nerve sheaths, which influences prognosis and treatment.
• Atypical Lobular Hyperplasia: Identifying high-risk benign breast lesions that require close clinical surveillance.
• Prostatic Adenocarcinoma: Confirming prostate cancer and calculating the Gleason score and Grade Group.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing timely, accurate, and highly reliable diagnostic reports. The turnaround time for a Biopsy, Slide(s) & Block(s) for review (Return to Patient) typically ranges from 3 to 5 working days. This timeline may vary depending on the complexity of the case, the need for additional cutting of paraffin blocks, or the performance of specialized immunohistochemical (IHC) stains to reach a definitive diagnosis. Chughtai Lab prioritizes urgent oncological cases to ensure that critical treatment decisions are not delayed.

Patients and referring physicians can easily access the completed pathology review reports through multiple convenient digital channels. Reports are available for download on the official Chughtai Lab website and the Chughtai Lab mobile application. Additionally, patients receive an SMS notification with a direct link to download their report as soon as it is signed off by the consultant pathologist. The physical glass slides and paraffin blocks are carefully packaged and made available for collection at the designated Chughtai Lab center, ensuring they are safely returned to the patient’s possession.

Biopsy, Slide(s) & Block(s) for review (Return to Patient) Findings Overview

The following table outlines the key parameters evaluated during a slide and block review, comparing normal tissue characteristics with potential pathological findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Cellular Morphology	Uniform cell size, shape, and normal nuclear-to-cytoplasmic ratio.	Pleomorphism, cellular atypia, enlarged nuclei, and hyperchromasia.
Tissue Architecture	Preserved, orderly arrangement of cells and intact basement membranes.	Disorganized growth, stromal invasion, cribriform patterns, or sheets of cells.
Mitotic Activity	Absent or rare, normal mitotic figures appropriate for the tissue type.	Atypical mitotic figures, elevated mitotic rate, high Ki-67 proliferation index.
Inflammatory Infiltrate	Absent or minimal, localized to appropriate physiological zones.	Dense acute or chronic inflammation, granuloma formation, microabscesses.
Vascular & Lymphatic Channels	Clear channels free of cellular debris or atypical cells.	Lymphovascular invasion (LVI), tumor emboli within vessel lumens.
Nerve Sheaths	Intact nerve bundles free of surrounding cellular atypia.	Perineural invasion (PNI), tumor cells wrapping around or invading nerves.
Surgical Margins	No tumor cells identified at the inked surgical resection margins.	Involved margins, tumor cells extending directly to the surgical ink.
Specialized Biomarkers (IHC)	Normal physiological expression of tissue-specific markers.	Aberrant expression, loss of tumor suppressor markers, or overexpression of oncogenes (e.g., HER2, ER/PR).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Biopsy, Slide(s) & Block(s) for review (Return to Patient)?

• Expert Consultant Pathologists: Your tissue samples are reviewed by highly qualified pathologists with extensive experience and subspecialty expertise.
• Advanced Histopathology Facilities: Chughtai Lab utilizes state-of-the-art automated staining and processing equipment to ensure excellent slide quality.
• Comprehensive IHC Menu: Access to a vast library of immunohistochemical markers for precise tumor subtyping and characterization.
• Strict Quality Assurance: The laboratory adheres to rigorous internal and external quality control protocols to guarantee diagnostic accuracy.
• Safe Specimen Handling: Robust tracking systems ensure that your valuable slides and blocks are handled with care and never misplaced.
• Guaranteed Return of Materials: A dedicated protocol ensures that all submitted slides and blocks are returned safely to the patient.
• Convenient Digital Access: View and download your detailed pathology reports online via the website or mobile app.
• Nationwide Network: Easily submit your diagnostic materials at any of the numerous Chughtai Lab collection centers across Pakistan.